According to foreign media WKMS, the first standardized medical cannabis extraction plant in Kentucky began construction in Carlyle County. It is reported that this project is an important symbol and milestone of the state’s “high-speed development of cannabis”. The Kentucky government attaches great importance to the project. Senator Julian Carroll and Justice Greg Terry of Kentucky attended the opening ceremony.
What does that have to do with Chinese marijuana companies?
Because Tan Xin, chairman of Hanma Group, the leading industrial hemp enterprise in China, also attended the opening ceremony.
Because the factory is a capital investment and technical support project of Hanma Group.
Because the plant all uses the hemp extraction and purification technology of Hansu Biotechnology Co., Ltd. of Hanma Group.
Because Hanma Group is the largest shareholder of the project.
It is reported that the Kentucky State Government attaches great importance to the project. Hanma Group and King’s Royal California Biological Company are selected as the cooperation units of the state government to be responsible for the implementation of the project. The project covers an area of 75,000 square feet with a total investment of nearly 40 million US dollars.
What does this project do specifically?
The Kentucky State Government has approved the qualification of industrial cannabis cultivation and processing and pharmaceutical cannabis diphenol (CBD) processing, and now all parties are actively implementing the project progress.
The Kentucky State Government and King’s Royal California Biotechnology Company have signed 2300 mu of industrial cannabis planting agreements with farmers in Carlisle and Hickman counties.
Schiavi Seeds provides AOSCA-certified legal cannabis provenances with high CBD and low THC.
The first batch of pharmaceutical grade CBD is expected to be completed by the end of 2018. The main products include CBD monomers and CBD full-spectrum oils.
CBD products will be widely used in pharmaceutical field as raw materials to help patients alleviate anxiety, inflammation, epilepsy, Crohn’s disease, diabetes, cancer and other diseases.
That is to say, Kentucky will become the home of pharmaceutical CBD production in the United States in the future, and will continue to provide health elements for those in need.
Tags: Chinese Cannabis Company, Cannabis Extraction Technology, Cannabis Separation Technology